10,033 Shares in Monsanto Company (MON) Acquired by Valeo Financial Advisors LLC
Valeo Financial Advisors LLC bought a new position in shares of Monsanto Company (NYSE:MON) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 10,033 shares of the basic materials company’s stock, valued at approximately $1,202,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Parkwood LLC lifted its stake in shares of Monsanto by 90.3% in the second quarter. Parkwood LLC now owns 11,665 shares of the basic materials company’s stock valued at $1,381,000 after buying an additional 5,535 shares in the last quarter. Kwmg LLC lifted its stake in shares of Monsanto by 465.8% in the second quarter. Kwmg LLC now owns 13,138 shares of the basic materials company’s stock valued at $1,555,000 after buying an additional 10,816 shares in the last quarter. Shell Asset Management Co. lifted its stake in shares of Monsanto by 3.9% in the second quarter. Shell Asset Management Co. now owns 163,710 shares of the basic materials company’s stock valued at $19,377,000 after buying an additional 6,087 shares in the last quarter. Cheyne Capital Management UK LLP bought a new position in shares of Monsanto in the second quarter valued at $28,346,000. Finally, Strs Ohio lifted its stake in shares of Monsanto by 31.4% in the second quarter. Strs Ohio now owns 364,636 shares of the basic materials company’s stock valued at $43,158,000 after buying an additional 87,165 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.
In related news, CFO Pierre Courduroux sold 4,320 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the sale, the chief financial officer now owns 48,388 shares in the company, valued at $5,903,336. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the sale, the chief operating officer now owns 85,439 shares of the company’s stock, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. Insiders have sold 49,236 shares of company stock valued at $5,931,934 in the last 90 days. 0.79% of the stock is currently owned by corporate insiders.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter in the prior year, the company posted $0.07 earnings per share. The firm’s revenue for the quarter was up 4.8% on a year-over-year basis. equities research analysts predict that Monsanto Company will post 5.74 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a yield of 1.84%. Monsanto’s dividend payout ratio (DPR) is presently 42.52%.
A number of research analysts have weighed in on the stock. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Wednesday, November 15th. Wells Fargo & Company raised their price objective on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. Barclays reaffirmed an “equal weight” rating and issued a $124.00 price objective (up from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Thursday, October 5th. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Monsanto currently has a consensus rating of “Hold” and an average price target of $124.61.
COPYRIGHT VIOLATION NOTICE: “10,033 Shares in Monsanto Company (MON) Acquired by Valeo Financial Advisors LLC” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.thecerbatgem.com/2017/12/11/10033-shares-in-monsanto-company-mon-acquired-by-valeo-financial-advisors-llc.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.